Donna Skee
Johnson & Johnson (United States)(US)Janssen (United States)(US)
Publications by Year
Research Areas
Reproductive Health and Contraception, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Pharmacological Effects and Toxicity Studies, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin(2012)221 cited
- → Absorption, Metabolism, and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men(2014)137 cited
- → Pharmacokinetic overview of Ortho Evra™/Evra™(2002)106 cited
- → Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants(2015)98 cited
- → Pharmacokinetics of a contraceptive patch (Evra™/Ortho Evra™) containing norelgestromin and ethinyloestradiol at four application sites(2002)91 cited
- → Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma(2012)84 cited
- → The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia(2015)74 cited
- → Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults(2015)70 cited
- → Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive(2007)63 cited
- → Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants(2001)49 cited